ERBB2 and breast carcinoma: The present report describes a 44-year-old female patient with recurrent metastatic PD-L1-negative, HER2-positive breast cancer, whose disease recurred in the chest wall during adjuvant treatment with T-DM1 (Kadcyla®) within 6 months.